BIOMAT Database Logo BIOMAT Database Logo

Preparation of affinity-fractionated, heparin-derived oligosaccharides and their effects on selected biological activities mediated by basic fibroblast growth factor. 1993

M Ishihara, and D J Tyrrell, and G B Stauber, and S Brown, and L S Cousens, and R J Stack
Glycomed Incorporated, Alameda, California 94501.

Homogeneously sized, heparin-derived oligosaccharides were prepared from heparin following partial depolymerization with nitrous acid, reduction with sodium borohydride, and fractionation by gel permeation chromatography. The resulting pools of di-, tetra-, hexa-, octa-, and decasaccharides were sequentially applied to an affinity column of human recombinant basic fibroblast growth factor (bFGF) covalently attached to Sepharose 4B and further fractionated into subpools based on their elution from this column in response to gradients of sodium chloride. In general, pools of smaller heparin-derived oligosaccharides required relatively lower salt concentration for complete elution, and pools of larger oligosaccharides required higher salt concentration. The homogeneously sized pools and affinity-fractionated subpools of heparin-derived oligosaccharides were quantitatively assessed as inhibitors or enhancers of specific bFGF-mediated biological activities in five separate assay systems as follows: assay 1, to compete with human lymphoblastoid cells expressing syndecan (RO-12 UC cells) for binding to bFGF-coated wells (Ishihara, M., Tyrrell, D.J., Kiefer, M.C., Barr, P.J., and Swiedler, S.J. (1992) Anal. Biochem. 202, 310-315); assay 2, to inhibit 125I-bFGF binding to "low affinity sites" of adrenocortical endothelial (ACE) cells; assay 3, to inhibit bFGF-induced proliferation of ACE cells; assay 4, to support mitogenic activity of bFGF in a growth stimulation assay of chlorate-treated ACE cells; and assay 5, to enhance the in vitro interaction between 125I-bFGF and the recombinant extra-cellular domain of FGF high affinity receptor. The data derived from the five assay systems demonstrated that heparin-derived hexa- and octasaccharides inhibited the interaction between cell surface heparan sulfate proteoglycan and bFGF (assays 1 and 2) and bFGF-induced proliferation of ACE cells (assay 3) but were unable to enhance the binding of bFGF to its high affinity receptor in vitro (assay 5) or to support bFGF-induced mitogenesis in ACE cells (assay 4). These two activities required at least a decasaccharide with high affinity for bFGF.

UI MeSH Term Description Entries
D009844 Oligosaccharides Carbohydrates consisting of between two (DISACCHARIDES) and ten MONOSACCHARIDES connected by either an alpha- or beta-glycosidic link. They are found throughout nature in both the free and bound form. Oligosaccharide
D002448 Cell Adhesion Adherence of cells to surfaces or to other cells. Adhesion, Cell,Adhesions, Cell,Cell Adhesions
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D002704 Chlorates Inorganic salts of chloric acid that contain the ClO3- ion. Chlorate
D002846 Chromatography, Affinity A chromatographic technique that utilizes the ability of biological molecules, often ANTIBODIES, to bind to certain ligands specifically and reversibly. It is used in protein biochemistry. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Chromatography, Bioaffinity,Immunochromatography,Affinity Chromatography,Bioaffinity Chromatography
D004727 Endothelium A layer of epithelium that lines the heart, blood vessels (ENDOTHELIUM, VASCULAR), lymph vessels (ENDOTHELIUM, LYMPHATIC), and the serous cavities of the body. Endotheliums
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006497 Heparitin Sulfate A heteropolysaccharide that is similar in structure to HEPARIN. It accumulates in individuals with MUCOPOLYSACCHARIDOSIS. Heparan Sulfate,Sulfate, Heparan,Sulfate, Heparitin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

M Ishihara, and D J Tyrrell, and G B Stauber, and S Brown, and L S Cousens, and R J Stack
Heparin-dependent fibroblast growth factor activities: effects of defined heparin oligosaccharides.
May 1997, European journal of cell biology,
M Ishihara, and D J Tyrrell, and G B Stauber, and S Brown, and L S Cousens, and R J Stack
Structural features in heparin which modulate specific biological activities mediated by basic fibroblast growth factor.
August 1994, Glycobiology,
M Ishihara, and D J Tyrrell, and G B Stauber, and S Brown, and L S Cousens, and R J Stack
Different effects of mucosal, bovine lung and chemically modified heparin on selected biological properties of basic fibroblast growth factor.
October 1994, The Biochemical journal,
M Ishihara, and D J Tyrrell, and G B Stauber, and S Brown, and L S Cousens, and R J Stack
Heparin-derived oligosaccharides: affinity for acidic fibroblast growth factor and effect on its growth-promoting activity for human endothelial cells.
September 1989, Journal of cellular physiology,
M Ishihara, and D J Tyrrell, and G B Stauber, and S Brown, and L S Cousens, and R J Stack
[Relationship between biological activity and heparin-affinity sites of recombinant human basic fibroblast growth factor CS23 mutein].
May 1999, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
M Ishihara, and D J Tyrrell, and G B Stauber, and S Brown, and L S Cousens, and R J Stack
Inhibition of basic fibroblast growth factor and vasculotropin biological activities on cultured cells by almitrine.
March 1995, Biochimica et biophysica acta,
M Ishihara, and D J Tyrrell, and G B Stauber, and S Brown, and L S Cousens, and R J Stack
Effects of basic fibroblast growth factor on biological characteristics of osteoblasts.
August 2003, Chinese journal of traumatology = Zhonghua chuang shang za zhi,
M Ishihara, and D J Tyrrell, and G B Stauber, and S Brown, and L S Cousens, and R J Stack
Stimulation of hepatocyte growth factor production by heparin-derived oligosaccharides.
May 2007, Journal of biochemistry,
M Ishihara, and D J Tyrrell, and G B Stauber, and S Brown, and L S Cousens, and R J Stack
Anticoagulant activities of heparin oligosaccharides and their neutralization by platelet factor 4.
March 1984, The Biochemical journal,
M Ishihara, and D J Tyrrell, and G B Stauber, and S Brown, and L S Cousens, and R J Stack
Isolation of brain fibroblast growth factor by heparin-Sepharose affinity chromatography: identity with pituitary fibroblast growth factor.
November 1984, Proceedings of the National Academy of Sciences of the United States of America,
Copied contents to your clipboard!